Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

EVGN Evogene Ltd

0.0408 (6.27%)
Dec 01 2023 - Closed
Delayed by 15 minutes


Draw Mode:

Volume 152,011
Bid Price 0.66
Ask Price 0.691
News -
Day High 0.718


52 Week Range


Day Low 0.66
Company Name Stock Ticker Symbol Market Type
Evogene Ltd EVGN NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.0408 6.27% 0.691 20:00:00
Open Price Low Price High Price Close Price Prev Close
0.68 0.66 0.718 0.691 0.6502
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
296 152,011 $ 0.6843285 $ 104,025 - 0.4502 - 1.44
Last Trade Time Type Quantity Stock Price Currency
19:27:05 2 $ 0.691 USD

Evogene Ltd Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
35.89M 50.55M - 5.18M -26.64M -0.53 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Evogene News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No EVGN Message Board. Create One! See More Posts on EVGN Message Board See More Message Board Posts

Historical EVGN Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.5880.7180.55030.6273557134,3880.10317.52%
1 Month0.550.7180.540.619969893,1990.14125.64%
3 Months0.760.790910.45020.5812987118,461-0.069-9.08%
6 Months0.611.440.45020.9472372242,0850.08113.28%
1 Year0.631.440.45020.8821192166,5910.0619.68%
3 Years3.6510.23860.45023.90414,213-2.96-81.07%
5 Years2.5610.23860.45023.66327,574-1.87-73.01%

Evogene Description

Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules and genetic elements as the core components for such products. It holds a number of subsidiaries utilizing the CPB platform, for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits and ag-solutions for castor oil production. It generates maximum revenue from the Agriculture segment.

Your Recent History

Delayed Upgrade Clock